BRBR - BellRing Brands, Inc.

BRBR

$8.36 0.30 (-3.46%) Last updated: May 31, 2026 03:51

52-Week Range

$8.36

$8.30 $8.36 $63.52

Fundamentals Overview

BellRing Brands, Inc. is near the low of its 52-week range with low valuation, trending downward today.

Valuation low

P/E 6.3 P/S 0.42

Intrinsic value (DCF)

+1126.3% upside vs price

Profitability

Net margin 6.8%

Risk (Beta)

0.81 — in line vol

Earnings & growth

EPS $1.33 Rev +11.4% Profit -22.4% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell

Buy

Hold — 54% confidence Risk: Moderate Volatility — Beta 0.81. Diversify and only invest what you can afford to lose.

Supporting (Buy):

DCF +1126.3% upside vs price · Analyst grade: B

Pressures (Sell):

Sentiment weakening (4 downgrades) · 3M vs S&P 500: -62.8% · 3M vs Consumer Defensive sector: -56.9%

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap

$972.08M

P/E (TTM)

6.27

EPS (TTM)

$1.33

Dividend Yield

N/A

52-Week Range

$8.30 - $63.52

Volume vs Avg

N/A

Beta

0.81

About

BellRing Brands, Inc., together with its subsidiaries, provides various nutrition products in the United States and internationally. It offers ready-to-drink shake and powder protein products primarily under the Premier Protein and Dymatize brands. The company sells its products through club, food, drug, mass, eCommerce, specialty, and convenience channels. BellRing Brands, Inc. was incorporated in 2019 and is headquartered in Saint Louis, Missouri.

Sector: Consumer Defensive

Headquarters: US

Employees: 485

IPO Date: Oct 2019

Website: bellring.com

Beta: 0.81 (Less volatile than market)

Ratings & Grades at a Glance

Overall rating: B. Recent institutional grades: majority downgrades. Current institutional positions: Buy: 10, Equal Weight: 1, Hold: 3, Market Perform: 1, Neutral: 6, Outperform: 1, Overweight: 8.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $102.52; current price is $8.36. That’s a +1126.3% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric	Value
Valuation
P/E (TTM)	6.27
DCF value (model)	$102.52 (1126.3% upside)
PEG (TTM)	N/A
P/B (TTM)	N/A
P/S (TTM)	0.42
P/FCF (TTM)	5.22
Liquidity & enterprise
Current Ratio (TTM)	2.52
Quick Ratio (TTM)	1.15
Cash Ratio (TTM)	0.11
Profitability
ROE (TTM)	N/A
ROA (TTM)	N/A
Revenue growth (YoY)	N/A
Net margin (TTM)	6.78%
Gross margin (TTM)	28.87%
Operating margin (TTM)	11.57%
Debt to equity (TTM)	N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for BRBR.

Analyst Sentiment at a Glance

B Sentiment Weakening

Buy 10Equal Weight 1Hold 3Market Perform 1Neutral 6Outperform 1Overweight 8

0 upgrades, 4 downgrades

Price Target Consensus

Current $8.36

Median $13.50

Consensus $18.75

Low consensus $11.00

High consensus $32.00

Stock Grades (Institutions)

Institution	Action	Previous Grade	New Grade	Date
DA Davidson	maintain	Buy	Buy	2026-05-15
Barclays	maintain	Overweight	Overweight	2026-05-07
Stifel	maintain	Buy	Buy	2026-05-06
Morgan Stanley	downgrade	Overweight	Equal Weight	2026-05-06
JP Morgan	maintain	Overweight	Overweight	2026-05-06
UBS	maintain	Neutral	Neutral	2026-05-06
TD Cowen	maintain	Hold	Hold	2026-05-06
Bernstein	downgrade	Outperform	Market Perform	2026-05-06
Morgan Stanley	maintain	Overweight	Overweight	2026-04-23
JP Morgan	maintain	Overweight	Overweight	2026-04-22
Barclays	maintain	Overweight	Overweight	2026-04-14
B of A Securities	maintain	Neutral	Neutral	2026-04-10
UBS	maintain	Neutral	Neutral	2026-04-07
Jefferies	maintain	Buy	Buy	2026-03-16
Mizuho	maintain	Outperform	Outperform	2026-03-05
DA Davidson	maintain	Buy	Buy	2026-02-05
Barclays	maintain	Overweight	Overweight	2026-02-05
DA Davidson	maintain	Buy	Buy	2026-02-04
Stifel	maintain	Buy	Buy	2026-02-04
DA Davidson	maintain	Buy	Buy	2026-01-28
Morgan Stanley	maintain	Overweight	Overweight	2026-01-16
UBS	maintain	Neutral	Neutral	2026-01-14
TD Cowen	maintain	Hold	Hold	2026-01-08
B of A Securities	maintain	Neutral	Neutral	2025-12-19
TD Cowen	downgrade	Buy	Hold	2025-11-20
DA Davidson	maintain	Buy	Buy	2025-11-20
Stifel	maintain	Buy	Buy	2025-11-19
B of A Securities	downgrade	Buy	Neutral	2025-11-19
Morgan Stanley	maintain	Overweight	Overweight	2025-11-19
DA Davidson	maintain	Buy	Buy	2025-11-19